National Health Investors Updates FY24 NAREIT FFO Per Diluted Share From $4.50-$4.54 To $4.39-$4.41; Normalized FFO Per Diluted Share From $4.52-$4.56 To $4.43-$4.44
National Health Investors Updates FY24 NAREIT FFO Per Diluted Share From $4.50-$4.54 To $4.39-$4.41; Normalized FFO Per Diluted Share From $4.52-$4.56 To $4.43-$4.44
Normalized FAD to a range of $201.8 million - $202.5 million from $200.1 million - $201.8 million;NHI is updating its 2024 annual guidance range which includes the following:
NHI正在更新其2024年的年度指引區間，其中包括以下內容：
NAREIT FFO per diluted common share to a range of $4.39 - $4.41 from $4.50 - $4.54;
NAREIt每股稀釋普通股的FFO從4.50美元至4.54美元調整至4.39美元至4.41美元；
Normalized FFO per diluted common share to a range of $4.43 - $4.44 from $4.52 - $4.56; and
每股稀釋普通股的標準化FFO從4.52美元至4.56美元調整至4.43美元至4.44美元；
Normalized FAD to a range of $201.8 million - $202.5 million from $200.1 million - $201.8 million;
標準化FAD調整爲20180萬至20250萬美元範圍內，而不是20010萬至20180萬美元；
NAREIT FFO and Normalized FFO revised guidance is primarily due to lower cash lease revenue and interest income assumptions, and a $3.6 million non-cash increase to the credit loss reserve attributable to Senior Living Management. This was partially offset by acquisitions closed since August 2024 funded primarily with forward equity proceeds;
NAREIt FFO和標準化FFO修訂指引主要是由於較低的現金租賃收入和利息收入假設，以及歸因於高齡生活管理層的360萬美元的非現金信貸損失準備金增加。這在一定程度上被自2024年8月以來主要使用股權融資的收購部分抵銷；
Normalized FAD revised guidance is primarily due to acquisitions closed since August 2024 offset by lower cash lease revenue and interest income assumptions attributable to Senior Living Management.
標準化FAD修訂指引主要是因爲自2024年8月以來的收購，部分抵銷了歸因於高齡生活管理層的較低的現金租賃收入和利息收入假設。
譯文內容由第三人軟體翻譯。
